Cormorant Asset Management, LP - Former 10% Owner at Elevation Oncology, Inc.

Issuer-level insider activity

Role
Former 10% Owner
Issuer ticker
ELEV
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Cormorant Asset Management, LP since 10 Sep 2025

Reported holdings for Cormorant Asset Management, LP in Elevation Oncology, Inc.

Form 4 holding Former 10% Owner

Elevation Oncology, Inc.

Security class
Common Stock
Shares / value
2,233,168
Estimated value
$1,138,916
Report date
29 Jun 2021
Price
$0.5100
Ownership
Indirect
Form 4 holding Former 10% Owner

Elevation Oncology, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
29 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Cormorant Asset Management, LP in Elevation Oncology, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .